TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Nov 16, 2015

Total Value ($000): $271,185 (91.3% shares, 8.7% debt)

Holdings (6)

HRTX HERON THERAPEUTICS INC 46.7%

Value ($000) $126,657 Shares 5,190,837 Est. Cost $12.86 Unrealized +159.1%

— LA JOLLA PHARMACEUTICAL CO 29.9%

Value ($000) $81,007 Shares 2,914,970 Est. Cost $14.41 Unrealized —

OPK OPKO HEALTH INC 7.7%

Value ($000) $20,815 Shares 2,475,000 Est. Cost $13.24 Unrealized 0.0%

BMRN BIOMARIN PHARMACEUTICAL INC 7.1%

Value ($000) $19,200 Shares 182,300 Est. Cost $62.32 Unrealized +114.3%

— OPKO HEALTH INC 6.7%

Value ($000) $18,247 Shares 14,000,000 Est. Cost $1.47 Unrealized —

— MERRIMACK PHARMACEUTICALS INC 1.9%

Value ($000) $5,259 Shares 3,500,000 Est. Cost $1.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
HRTX	HERON THERAPEUTICS INC	5,190,837	$126,657	46.7%	$12.86	+159.1%	COM	427746102
—	LA JOLLA PHARMACEUTICAL CO	2,914,970	$81,007	29.9%	$14.41	—	COM	503459604
OPK	OPKO HEALTH INC	2,475,000	$20,815	7.7%	$13.24	0.0%	COM	68375N103
BMRN	BIOMARIN PHARMACEUTICAL INC	182,300	$19,200	7.1%	$62.32	+114.3%	COM	09061G101
—	OPKO HEALTH INC	14,000,000	$18,247	6.7%	$1.47	—	DEBT 3.0% 2/1/33	68375NAB9
—	MERRIMACK PHARMACEUTICALS INC	3,500,000	$5,259	1.9%	$1.36	—	NOTE 4.5% 7/15/20	590328AA8